Gene | Variant | Comparison | Country (no. of studies) | Ethnicity | OR (95% CI) | # cases | # controls | I2 value |
---|---|---|---|---|---|---|---|---|
CYP2E1 | Rs2080672 | Het (AG) vs Hom WT (AA) | China (1 study) | NR | 1.16 (0.72, 1.89) | 86 | 334 | N/A |
Hom MT (GG) vs Hom WT (AA) | China (1 study) | NR | 0.69 (0.19, 2.42) | 54 | 228 | N/A | ||
Rs915908 | Het (GA) vs Hom WT (GG) | China (1 study) | NR | 0.89 (0.47, 1.69) | 79 | 318 | N/A | |
Hom MT (AA) vs Hom WT (GG) | China (1 study) | NR | 1.09 (0.52, 2.32) | 75 | 292 | N/A | ||
Rs8192775 | Het (GA) vs Hom WT (GG) | China (1 study) | NR | 1.17 (0.72, 1.90) | 85 | 333 | N/A | |
Hom MT (AA) vs Hom WT (GG) | China (1 study) | NR | 0.76 (0.25, 2.29) | 55 | 234 | N/A | ||
Rs2515641 | Het (CT) vs Hom WT (CC) | China (1 study) | NR | 1.20 (0.73, 1.99) | 85 | 342 | N/A | |
Hom MT (TT) vs Hom WT (CC) | China (1 study) | NR | 1.31 (0.41, 4.18) | 60 | 252 | N/A | ||
Rs2515644 | Het (CA) vs Hom WT (CC) | China (1 study) | NR | 1.26 (0.74, 2.15) | 73 | 285 | N/A | |
Hom MT (AA) vs Hom WT (CC) | China (1 study) | NR | 1.04 (0.52, 2.08) | 42 | 186 | N/A | ||
Rs2070672 | Het (AG) vs Hom WT (AA) | South Korea (1 study) | NR | 1.74 (0.93, 3.25) | 63 | 149 | N/A | |
Hom MT (GG) vs Hom WT (AA) | South Korea (1 study) | NR | 0.94 (0.18, 4.85) | 41 | 116 | N/A | ||
Rs2070673a | Het (TA) vs Hom WT (TT) | South Korea (1 study) | NR | 0.88 (0.48, 1.63) | 59 | 134 | N/A | |
Hom MT (AA) vs Hom WT (TT) | South Korea (1 study) | NR | 0.75 (0.28, 1.96) | 37 | 84 | N/A | ||
96-bp (deletion-insertion SNP) | Het (DI) vs Hom WT (DD) | India (1 study) | NR | 1.13 (0.22, 5.88) | 6 | 98 | N/A | |
Brazil (1 study) | NR | 0.25 (0.01, 4.26) | 18 | 228 | N/A | |||
All (2 studies) | 0.77 (0.19, 3.21) | 24 | 326 | 0.0% | ||||
Hom MT (II) vs Hom WT (DD) | India (1 study) | NR | 11.56 (1.37, 97.67) | 5 | 55 | N/A | ||
Brazil (1 study) | NR | 3.72 (0.15, 94.60) | 18 | 207 | N/A | |||
All (2 studies) | 8.20 (1.38, 48.68) | 23 | 262 | 0.0% | ||||
CYP2C9 | Rs4918758b | Het (TC) vs Hom WT (TT) | China (1 study) | NR | 0.78 (0.46, 1.33) | 69 | 285 | N/A |
South Korea (1 study) | NR | 1.66 (0.85, 3.23) | 59 | 127 | N/A | |||
All (2 studies) | 1.11 (0.53, 2.31) | 128 | 412 | 66.7% | ||||
Hom MT (CC) vs Hom WT (TT) | China (1 study) | NR | 0.94 (0.49, 1.80) | 51 | 188 | N/A | ||
South Korea (1 study) | NR | 0.72 (0.27, 1.95) | 24 | 80 | N/A | |||
All (2 studies) | 0.87 (0.51, 1.50) | 75 | 268 | 0.0% | ||||
Rs9332098 | Het (GA) vs Hom WT (GG) | China (1 study) | NR | 0.32 (0.07, 1.38) | 88 | 354 | N/A | |
Hom MT (AA) vs Hom WT (GG) | China (1 study) | NR | Data excludedc | |||||
Rs9332096 | Het (CT) vs Hom WT (CC) | South Korea (1 study) | NR | 0.63 (0.27, 1.47) | 66 | 156 | N/A | |
Hom MT (TT) vs Hom WT (CC) | South Korea (1 study) | NR | 0.73 (0.03, 18.24) | 58 | 129 | N/A | ||
Rs1057910 | Het (AC) vs Hom WT (AA) | South Korea (1 study) | NR | 1.00 (0.34, 2.97) | 64 | 154 | N/A | |
Hom MT (CC) vs Hom WT (AA) | South Korea (1 study) | NR | Data excludedc | |||||
CYP2B6 | rs3745274 | Het (GT) vs Hom WT (GG) | Brazil (1 study) | NR | 1.57 (0.71, 3.45) | 30 | 176 | N/A |
Ethiopia (1 study) | NR | 1.42 (0.68, 2.98) | 35 | 145 | N/A | |||
All (2 studies) | 1.49 (0.87, 2.55) | 65 | 321 | 0.0% | ||||
Hom MT (TT) vs Hom WT (GG) | Brazil (1 study) | NR | 0.58 (0.07, 4.81) | 13 | 103 | N/A | ||
Ethiopia (1 study) | NR | 1.98 (0.66, 5.87) | 22 | 94 | N/A | |||
All (2 studies) | 1.51 (0.55, 4.13) | 35 | 197 | 4.2% | ||||
CYP3A4 | rs12333983 | Het (TA) vs Hom WT (TT) | China (1 study) | NR | 1.33 (0.81, 2.18) | 78 | 312 | N/A |
Hom MT (AA) vs Hom WT (TT) | China (1 study) | NR | 1.33 (0.62, 2.86) | 47 | 204 | N/A | ||
-392 A-G | Het (GA) vs Hom WT (AA) | Brazil (1 study) | 42% white, 58% non-white | 0.69 (0.32, 1.47) | 45 | 69 | N/A | |
Hom MT (GG) vs Hom WT (AA) | Brazil (1 study) | 42% white, 58% non-white | 0.91 (0.31, 2.70) | 34 | 45 | N/A | ||
CYP2C19 | rs11568732 | Het (TG) vs Hom WT (TT) | China (1 study) | NR | 0.54 (0.25, 1.19) | 87 | 350 | N/A |
Hom MT (GG) vs Hom WT (TT) | China (1 study) | NR | 0.93 (0.10, 8.47) | 80 | 229 | N/A | ||
rs4986894 | Het (TC) vs Hom WT (TT) | China (1 study) | NR | 0.95 (0.57, 1.59) | 72 | 302 | N/A | |
Hom MT (CC) vs Hom WT (TT) | China (1 study) | NR | 1.11 (0.53, 2.32) | 48 | 191 | N/A | ||
rs17878465 | Het (CT) vs Hom WT (CC) | South Korea (1 study) | NR | 0.99 (0.50, 1.94) | 65 | 153 | N/A | |
Hom MT (TT) vs Hom WT (CC) | South Korea (1 study) | NR | 0.33 (0.02, 6.58) | 49 | 118 | N/A | ||
rs4986893 | Het (GA) vs Hom WT (GG) | South Korea (1 study) | NR | 0.69 (0.31, 1.56) | 66 | 156 | N/A | |
Hom MT (AA) vs Hom WT (GG) | South Korea (1 study) | NR | 0.74 (0.03, 18.42) | 57 | 128 | N/A | ||
CYP3A5 | rs776746 | Het (AG) vs Hom WT (AA) | Brazil (1 study) | NR | 1.84 (0.83, 4.05) | 31 | 189 | N/A |
Hom MT (GG) vs Hom WT (AA) | Brazil (1 study) | NR | Data excludedc | |||||
Number of CYP3A5*1 | One copy vs zero copies | Ethiopia (1 study) | NR | 1.56 (0.76, 3.20) | 39 | 151 | N/A | |
Two copies vs zero copies | Ethiopia (1 study) | NR | 1.02 (0.21, 5.05) | 24 | 110 | N/A | ||
CYP1A1 | MspI | Hom MT or Het vs Hom WT | China (1 study) | NR | 1.33 (0.81, 2.19) | 127 | 127 | N/A |
CYP2D6 | rs1080983 | Het (GA) vs Hom WT (AA) | South Korea (1 study) | NR | 0.83 (0.43, 1.61) | 65 | 152 | N/A |
Hom MT (GG) vs Hom WT (AA) | South Korea (1 study) | NR | 0.56 (0.06, 5.11) | 50 | 113 | N/A | ||
rs1080989 | Het (GA) vs Hom WT (AA) | South Korea (1 study) | NR | 0.89 (0.45, 1.74) | 50 | 121 | N/A | |
Hom MT (GG) vs Hom WT (AA) | South Korea (1 study) | NR | 1.03 (0.47, 2.27) | 36 | 80 | N/A |